News

Oncology Experts: A Central Source for Insights and Strategic Analysis

Select Your Filters

Bio Tech CI AML CLL NHL IO Modalities tumor microenvironment modulation Targeted Immunotherapies Cell-based Platforms Combination Therapy Pharma Strategy ASH2026 Mechanism of Actions MOAs SITC 2026 Immuno-Oncology bispecific antibodies Gliomas SNO 2026 risvutatug rezetecan tambotatug pelitecan ImmunoOncology Triple Negative SABCS Clinical Research HR+ gBRACAm Breast Cancer Competitive Intelligence Oncology CI ASH First Phase III data MPNs MDS MM ALL Lymphoma Leukemia Biopharma Hematology Lung PARP inhibitors vaccines Checkpoint inhibition ADC targets PD-(L)1 RAS B7-H3 TROP-2 HER2 PD-1 ADCs clinical data KRAS Pharma CI Cancer Research SCLC Lung Cancer Oncology ESMO 2026 anti-PD-1 monotherapy CN Phase III data ROS1+ zidesamtinib zipalertinib Clinical Trials Oncology Insights Competitive Insights WCLC 2026 Oncology Intelligence NSCLC monotherapy HNSCC Melanoma EGFR x cMET cMET EGFR PD-1 x VEGF VEGF

Clear filters

Sort

Featured Story

November 12, 2026Regina Cheung, Ph.D., Patrick Nygren, Ph.D. and Jillian R. James

Headed to ASH 2026 in New Orleans? So are we!

The ONCrg (Oncology Resource Group) team will be on-site tracking key data readouts, clinical paradigm shifts, and strategic pipeline updates across hematology. Here’s what our analyst team is monitoring based on...

No results. Try clearing a filter or searching for something else.

Footer

OncologyResource Group

Expert, Content-Focused Insights

ONCrg Full Support

ONCrg Full Support
ONCrg Pipeline Strategies
ONCrg Conference
ONCrg Sentinel
ONCrg Advisory

Resources

About ONCrg

About
Our Team
Careers
Contact
Home Page

Solid Tumors

Bladder
Breast
Colorectal
Endometrial
Esophageal
Gastric
Gliomas
HCC
HNSCC
Melanoma
NSCLC
Ovarian
Pancreatic
Prostate
RCC
SCLC
STS*

Hematologic Malignancies

ALL
AML
CLL
MDS
MM
MPNs
NHL

Immuno-Onc

Emerging IO
Late Stage IO

MOAs

ADCs
Cancer Vaccines*
Cell Therapies
DDR*
Emerging Clinical Signals*

Conferences

ASCO GI
ASCO GU
ELCC
SGO
AACR
ASCO
ICML
EHA
WCLC
ESMO
SITC
SNO
SABCS
ASH

Oncology Resource Group
Stacey Hood +1 314.695.2733

BioPharma Resource Groups
Michael Reynolds +1 650.485.2626

CardioVascular Resource Group
Stacey Hood +1 314.695.2733

Sample Request

How Did You Hear About Us

ONCrg uses cookies to provide a personalized user experience and to ensure secure access to our website content. View our GDPR and Privacy Policies.
I agree No